 SAN DIEGO, Oct. 27, 2020 GLOBE NEWSWIRE -- Exagen Inc. Nasdaq: XGN, an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that it will release financial results for the quarter ended September 30, 2020 after the market close on Tuesday, November 10, 2020. Ron Rocca, President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Companys results at 4:30 PM Eastern Time 1:30 PM Pacific Time. 